Most Popular Articles

CLINICOPATHOLOGIC CORRELATION OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION

Li, Miaoling; Dolz-Marco, Rosa; Huisingh, Carrie; More

RETINA. 39(4):802-816, April 2019.

OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Khanani, Arshad M.; Eichenbaum, David; Schlottmann, Patricio G.; More

RETINA. 38(11):2103-2117, November 2018.

ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION

Bonnin, Sophie; Dupas, Bénédicte; Lavia, Carlo; More

RETINA. 39(3):426-434, March 2019.

EFFECT OF INTRAOCULAR PRESSURE–LOWERING MEDICATIONS ON NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATMENT OUTCOMES IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENT TRIALS

Rahimy, Ehsan; Ying, Gui-shuang; Pan, Wei; More

RETINA. 39(4):636-647, April 2019.

PREVALENCE AND CLINICAL CHARACTERISTICS OF PACHYDRUSEN IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Multimodal Image Study

Lee, Junwon; Byeon, Suk Ho

RETINA. 39(4):670-678, April 2019.

MACULAR HOLE HYDRODISSECTION: Surgical Technique for the Treatment of Persistent, Chronic, and Large Macular Holes

Felfeli, Tina; Mandelcorn, Efrem D.

RETINA. 39(4):743-752, April 2019.

CORRELATIONS BETWEEN EXPERIMENTAL MYOPIA MODELS AND HUMAN PATHOLOGIC MYOPIA

Vutipongsatorn, Kritchai; Nagaoka, Natsuko; Yokoi, Tae; More

RETINA. 39(4):621-635, April 2019.

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB

Avery, Robert L.; Castellarin, Alessandro A.; Steinle, Nathan C.; More

Retina. 37(10):1847-1858, October 2017.

INTRAVITREAL ZIV-AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results

de Oliveira Dias, João R.; Costa de Andrade, Gabriel; Kniggendorf, Vinicius F.; More

RETINA. 39(4):648-655, April 2019.

CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY

Fine, Howard F.; Reshef, Edith R.; Prenner, Jonathan L.; More

RETINA. 39(4):761-765, April 2019.

EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the VIEW Trials

Wong, Tien Yin; Cheung, Chui Ming Gemmy; Lai, Timothy Y. Y.; More

RETINA. 39(3):537-547, March 2019.

ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration

Daruich, Alejandra; Matet, Alexandre; Marchionno, Laetitia; More

Retina. 37(10):1905-1915, October 2017.

INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Vazquez-Alfageme, Clara; Nicholson, Luke; Hamilton, Robin D.; More

RETINA. 39(4):664-669, April 2019.

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN RETINAL VEIN OCCLUSION: Correlations Between Macular Vascular Density, Visual Acuity, and Peripheral Nonperfusion Area on Fluorescein Angiography

Seknazi, Daniel; Coscas, Florence; Sellam, Alexandre; More

RETINA. 38(8):1562-1570, August 2018.

VESSEL DENSITY OF SUPERFICIAL, INTERMEDIATE, AND DEEP CAPILLARY PLEXUSES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

Lavia, Carlo; Bonnin, Sophie; Maule, Milena; More

RETINA. 39(2):247-258, February 2019.

LONG-TERM OUTCOMES OF RANIBIZUMAB TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION IN EAST-ASIAN PATIENTS FROM THE RADIANCE STUDY

Tan, Nikolle W.; Ohno-Matsui, Kyoko; Koh, Hyoung J.; More

RETINA. 38(11):2228-2238, November 2018.

APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION

Cheng, Ying; Li, Ying; Huang, Xin; More

RETINA. 39(4):712-718, April 2019.

FIVE-YEAR INCIDENCE AND RISK FACTORS FOR IDIOPATHIC EPIRETINAL MEMBRANES

Bae, Jeong Hun; Song, Su Jeong; Lee, Mi Yeon

RETINA. 39(4):753-760, April 2019.

FLUORESCEIN ANGIOGRAPHIC EVALUATION OF PERIPHERAL RETINAL VASCULATURE AFTER PRIMARY INTRAVITREAL RANIBIZUMAB FOR RETINOPATHY OF PREMATURITY

Harper, C. Armitage III; Wright, Lauren M.; Young, Ryan C.; More

RETINA. 39(4):700-705, April 2019.

EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Arendt, Petra; Yu, Siqing; Munk, Marion R.; More

RETINA. 39(1):27-33, January 2019.

HISTOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Multilayer Approach

Li, Miaoling; Huisingh, Carrie; Messinger, Jeffrey; More

RETINA. 38(10):1937-1953, October 2018.

MANAGEMENT OF NEOVASCULAR OCULAR HISTOPLASMOSIS: Past and Present

Blinder, Kevin J.

RETINA. 39(2):226-234, February 2019.

AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION: The ARI2 Study

Blanco-Garavito, Rocio; Jung, Camille; Uzzan, Joel; More

RETINA. 38(12):2285-2292, December 2018.

ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data

Dugel, Pravin U.; Campbell, Joanna H.; Kiss, Szilárd; More

RETINA. 39(1):88-97, January 2019.

SURGICAL OUTCOMES OF 27-GAUGE VITRECTOMY FOR A CONSECUTIVE SERIES OF 163 EYES WITH VARIOUS VITREOUS DISEASES

Yoneda, Kazuhito; Morikawa, Keisuke; Oshima, Yusuke; More

Retina. 37(11):2130-2137, November 2017.

RETINAL ARTERY OCCLUSION AFTER INTRAVASCULAR PROCEDURES: Case Series and Literature Review

Cho, Soo Chang; Jung, Cheolkyu; Lee, Joo Yong; More

RETINA. 39(4):766-778, April 2019.

CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA

Hirano, Takao; Toriyama, Yuichi; Iesato, Yasuhiro; More

RETINA. 38(9):1801-1808, September 2018.

LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY

Allahdina, Ali M.; Chen, Katherine G.; Alvarez, Jason A.; More

RETINA. 39(3):473-484, March 2019.

COLORADO AGE-RELATED MACULAR DEGENERATION REGISTRY: Design and Clinical Risk Factors of the Cohort

Lynch, Anne M.; Patnaik, Jennifer L.; Cathcart, Jennifer N.; More

RETINA. 39(4):656-663, April 2019.

TREATMENT PATTERNS AND 2-YEAR VISION OUTCOMES WITH BEVACIZUMAB IN DIABETIC MACULAR EDEMA: An Analysis From a Large U.S. Integrated Health Care System

Fong, Donald S.; Luong, Tiffany Q.; Contreras, Richard; More

RETINA. 38(9):1830-1838, September 2018.

PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION

Chan, Clement K.; Crosson, Jason N.; Mein, Calvin E.; More

Retina. 37(10):1820-1831, October 2017.

PREOPERATIVE FACTORS INFLUENCING VISUAL RECOVERY AFTER VITRECTOMY FOR MYOPIC FOVEOSCHISIS

Lehmann, Mathieu; Devin, François; Rothschild, Pierre-Raphael; More

RETINA. 39(3):594-600, March 2019.

PROSPECTIVE RANDOMIZED TRIAL ASSESSING THE IMPACT OF FEEDBACK MECHANISMS ON PATIENT POSITIONING

Dimopoulos, Spyridon; Vivell, Julian; Ziemssen, Focke; More

RETINA. 39(4):727-735, April 2019.

VASCULAR DISTORTION AND DRAGGING RELATED TO APPARENT TISSUE CONTRACTION IN MACULAR TELANGIECTASIS TYPE 2

Spaide, Richard F.; Marco, Rosa D.; Yannuzzi, Lawrence A.

Retina. 38:S51-S60, January 2018.

PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY: Detailed Clinical Study of a Large Cohort

Shona, Olajumoke a; Islam, Farrah; Robson, Anthony G.; More

RETINA. 39(3):514-529, March 2019.

SURGICAL REMOVAL OF EPIRETINAL MEMBRANE WITH AND WITHOUT REMOVAL OF INTERNAL LIMITING MEMBRANE: Comparative Study of Visual Acuity, Features of Optical Coherence Tomography, and Recurrence Rate

De Novelli, Fernando J.; Goldbaum, Mauro; Monteiro, Mario L. R.; More

RETINA. 39(3):601-607, March 2019.

EARLY MICROVASCULAR AND NEURAL CHANGES IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY

Vujosevic, Stela; Muraca, Andrea; Alkabes, Micol; More

RETINA. 39(3):435-445, March 2019.

PARS PLANA VITRECTOMY AND WIDE INTERNAL LIMITING MEMBRANE PEELING WITH PERFLUOROPROPANE TAMPONADE FOR HIGHLY MYOPIC FOVEOSCHISIS–ASSOCIATED MACULAR HOLE

Zhang, Zhaotian; Wei, Yantao; Jiang, Xintong; More

Retina. 37(2):274-282, February 2017.

REPEATABILITY OF CHOROIDAL THICKNESS MEASUREMENTS ASSESSED WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY IN HEALTHY AND DIABETIC INDIVIDUALS

Abadía, Beatriz; Calvo, Pilar; Bartol-Puyal, Francisco; More

RETINA. 39(4):786-793, April 2019.

MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA

Miserocchi, Elisabetta; Ferreri, Andrés J. M.; Giuffrè, Chiara; More

RETINA. 39(4):679-684, April 2019.

RETINAL TELANGIECTASIA IN PATIENTS WITH PATHOLOGIC MYOPIA: A CASE SERIES

Lei, Boya; Gu, Ruiping; Jiang, Chen; More

RETINA. 39(4):719-726, April 2019.

CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS

Osaka, Rie; Shiragami, Chieko; Ono, Aoi; More

Retina. 38:S114-S122, January 2018.

EFFECT OF AN INTRAVITREAL DEXAMETHASONE IMPLANT ON DIABETIC MACULAR EDEMA AFTER CATARACT SURGERY

Calvo, Pilar; Ferreras, Antonio; Al Adel, Fadwa; More

Retina. 38(3):490-496, March 2018.

COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY

Zhang, Guoming; Yang, Mingmin; Zeng, Jian; More

Retina. 37(4):710-717, April 2017.

THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters

Sadda, SriniVas R.; Dugel, Pravin U.; Gonzalez, Victor H.; More

RETINA. 39(2):319-330, February 2019.

MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Takasago, Yukari; Shiragami, Chieko; Kobayashi, Mamoru; More

RETINA. 39(2):296-302, February 2019.

VASCULAR REMODELING OF CHOROIDAL NEOVASCULARIZATION AFTER ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VISUALIZED ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

Miere, Alexandra; Butori, Pauline; Cohen, Salomon Y.; More

RETINA. 39(3):548-557, March 2019.

RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION

Matsumoto, Makiko; Suzuma, Kiyoshi; Yamada, Yoshihisa; More

Retina. 38(2):283-291, February 2018.

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE

Kowalczuk, Laura; Matet, Alexandre; Dirani, Ali; More

Retina. 37(12):2226-2237, December 2017.

TRAFFIC ACCIDENT–RELATED OPEN GLOBE INJURIES

Okamoto, Yoshifumi; Morikawa, Shohei; Okamoto, Fumiki; More

RETINA. 39(4):779-785, April 2019.

CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6–The MacTel Research Group

Peto, Tunde; Heeren, Tjebo F. C.; Clemons, Traci E.; More

Retina. 38:S8-S13, January 2018.

CHARACTERIZATION OF THE MIDDLE CAPILLARY PLEXUS USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN HEALTHY AND DIABETIC EYES

Park, Justin J.; Soetikno, Brian T.; Fawzi, Amani A.

Retina. 36(11):2039-2050, November 2016.

COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA: Two-Year Randomized Single-Blind Controlled Trial Results

Lafuente, María; Ortín, Lourdes; Argente, María; More

Retina. 37(7):1277-1286, July 2017.

OPTICAL DENSITY RATIO OF THE SUBRETINAL FLUID IN CHOROIDAL MELANOMA AND METASTASIS

Leshno, Ari; Vishnevskia-Dai, Vicktoria; Barak, Adiel; More

RETINA. 39(4):685-691, April 2019.

THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY

Sancak, Selim; Toptan, Handan H.; Gokmen Yildirim, Tulin; More

RETINA. 39(4):706-711, April 2019.

FACTORS ASSOCIATED WITH SEROUS RETINAL DETACHMENT IN HIGHLY MYOPIC EYES WITH VERTICAL OVAL-SHAPED DOME

García-Ben, Antonio; Sanchez, María J. MORILLO; Gómez, Ana GONZALEZ; More

RETINA. 39(3):587-593, March 2019.

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

Iglicki, Matias; Busch, Catharina; Zur, Dinah; More

RETINA. 39(1):44-51, January 2019.

FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial

Nti, Akosua A.; Serrano, Leona W.; Sandhu, Harpal S.; More

RETINA. 39(3):502-513, March 2019.

OUTCOMES OF VITRECTOMY WITH SILICONE OIL TAMPONADE FOR MANAGEMENT OF RETINAL DETACHMENT IN EYES WITH CHORIORETINAL COLOBOMA

Hocaoglu, Mumin; Karacorlu, Murat; Ersoz, Mehmet G.; More

RETINA. 39(4):736-742, April 2019.

SILICONE MICROTUBE–ASSISTED SCLERAL FIXATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS

Kataoka, Takuya; Kamei, Motohiro

RETINA. 38:S146-S153, September 2018.

HIV-ASSOCIATED RETINOPATHY IN THE HAART ERA

GOLDBERG, DANIEL E.; SMITHEN, LINDSAY M.; ANGELILLI, ALLISON; More

Retina. 25(5):633-649, July-August 2005.

VASCULAR ABNORMALITIES IN DIABETIC RETINOPATHY ASSESSED WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WIDEFIELD IMAGING

Schaal, Karen B.; Munk, Marion R.; Wyssmueller, Iris; More

RETINA. 39(1):79-87, January 2019.

CORRELATION BETWEEN CYSTOID SPACES IN CHRONIC DIABETIC MACULAR EDEMA AND CAPILLARY NONPERFUSION DETECTED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY

Mané, Valérie; Dupas, Bénédicte; Gaudric, Alain; More

Retina. 36:S102-S110, December 2016.

TREATMENT OF EXUDATIVE CIRCUMSCRIBED CHOROIDAL HEMANGIOMA: Efficacy of Fractionated Proton Therapy (20 Gray Relative Biological Effectiveness in 8 Fractions)

Mahdjoubi, Amir; Dendale, Rémi; Desjardins, Laurence; More

RETINA. 39(4):692-699, April 2019.

LEAN SIX SIGMA TECHNIQUES TO IMPROVE OPHTHALMOLOGY CLINIC EFFICIENCY

Ciulla, Thomas A.; Tatikonda, Mohan V.; ElMaraghi, Yehya A.; More

RETINA. 38(9):1688-1698, September 2018.

RETINAL PIGMENT EPITHELIUM–CHOROID GRAFT WITH A PERIPHERAL RETINOTOMY FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Long-Term Outcome

van Romunde, Saskia H. M.; Polito, Antonio; Peroglio Deiro, Antonio; More

RETINA. 39(2):288-295, February 2019.

CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA

Leung, Irene; Sallo, Ferenc B.; Bonelli, Roberto; More

Retina. 38:S43-S50, January 2018.

CELLULAR IMAGING OF THE TAPETAL-LIKE REFLEX IN CARRIERS OF RPGR-ASSOCIATED RETINOPATHY

Kalitzeos, Angelos; Samra, Ranjit; Kasilian, Melissa; More

RETINA. 39(3):570-580, March 2019.

EFFECT OF DARK ADAPTATION AND BLEACHING ON BLUE LIGHT REFLECTANCE IMAGING IN MACULAR TELANGIECTASIA TYPE 2

Okada, Mali; Heeren, Tjebo F. C.; Egan, Catherine A.; More

Retina. 38:S89-S96, January 2018.

THREE-DIMENSIONAL ANALYSIS OF RETINAL MICROANEURYSMS WITH ADAPTIVE OPTICS OPTICAL COHERENCE TOMOGRAPHY

Karst, Sonja G.; Salas, Matthias; Hafner, Julia; More

RETINA. 39(3):465-472, March 2019.

CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA

Sallo, Ferenc B.; Leung, Irene; Clemons, Traci E.; More

Retina. 38:S27-S32, January 2018.

SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF FELLOW EYES IN COATS DISEASE

Stanga, Paulo E.; Romano, Francesco; Chwiejczak, Katarzyna; More

RETINA. 39(3):608-613, March 2019.

TRAUMATIC PROLIFERATIVE VITREORETINOPATHY: Clinical and Histopathological Observations

Jin, Ying; Chen, Huijin; Xu, Xiaojian; More

Retina. 37(7):1236-1245, July 2017.

LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2

Heeren, Tjebo F. C.; Kitka, Diána; Florea, Daniela; More

Retina. 38:S20-S26, January 2018.

FEATURES OF OPTICAL COHERENCE TOMOGRAPHY FOR THE DIAGNOSIS OF VOGT–KOYANAGI–HARADA DISEASE

Liu, Xi Yao; Peng, Xiao Yan; Wang, Shuang; More

Retina. 36(11):2116-2123, November 2016.

COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE

Weiss, Maximilian; Sim, Dawn A.; Herold, Tina; More

RETINA. 38(12):2293-2300, December 2018.

EYES WITH SUBRETINAL DRUSENOID DEPOSITS AND NO DRUSEN: Progression of Macular Findings

Spaide, Richard F.; Yannuzzi, Lawrence; Freund, K. Bailey; More

RETINA. 39(1):12-26, January 2019.

EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy

Birch, David G.; Benz, Matthew S.; Miller, Daniel M.; More

Retina. 38(2):364-378, February 2018.

MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment

Santos, Ana Rita; Alves, Dalila; Santos, Torcato; More

RETINA. 39(1):52-60, January 2019.

CHANGES IN CHOROIDAL THICKNESS IN AND OUTSIDE THE MACULA AFTER HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE

Chang, In Boem; Lee, Jeong Hyun; Kim, Jae Suk

Retina. 37(5):896-905, May 2017.

CHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report

Bressler, Susan B.; Odia, Isoken; Glassman, Adam R.; More

RETINA. 38(10):1896-1904, October 2018.

MACULAR TELANGIECTASIA TYPE 2: Quantitative Analysis of a Novel Phenotype and Implications for the Pathobiology of the Disease

Okada, Mali; Egan, Catherine A.; Heeren, Tjebo F. C.; More

Retina. 38:S97-S104, January 2018.

COMPARING MICROPERIMETRIC AND STRUCTURAL FINDINGS IN PATIENTS WITH BRANCH RETINAL VEIN OCCLUSION AND DIABETIC MACULAR EDEMA

Sachdev, Amun; Edington, Magdalena; Morjaria, Rupal; More

RETINA. 39(3):446-451, March 2019.

PACHYCHOROID PIGMENT EPITHELIOPATHY

Warrow, David J.; Hoang, Quan V.; Freund, K. Bailey

Retina. 33(8):1659-1672, September 2013.

AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight–Week Outcomes

Bahrami, Bobak; Hong, Thomas; Schlub, Timothy E.; More

RETINA. 39(1):61-68, January 2019.

CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA

Chakravarthy, Usha; Yang, Yit; Lotery, Andrew; More

Retina. 38(2):343-351, February 2018.